It is Thursday and the FOMC meeting has come and gone. With stocks again challenged new all-time highs, investors and traders keep being told that the bull market has morphed into a stock picker’s market. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week, hunting for new ideas for our readers. Some of these Wall Street research reports cover stocks to buy, while some cover stocks to sell or to avoid.
These are this Thursday’s top Wall Street analyst upgrades, downgrades and initiations.
Amazon.com Inc. (NASDAQ: AMZN) was reiterated as Outperform and the price target is $439 at Credit Suisse. The firm talked up the new phone as driving Amazon Prime adoption and incremental transactions.
AngioDynamics Inc. (NASDAQ: ANGO) was raised to Buy from Hold and the price target was raised to $20 from $16.26 at Canaccord Genuity, based on the notion that its cash is flowing and business is improving.
Atlantic Power Corp. (NYSE: AT) was raised to Sector Perform from Underperform at RBC Capital Markets.
Celgene Corp. (NASDAQ: CELG) was reiterated as Outperform and the price target was raised to $225 from $210 at Credit Suisse. The analyst report says that while its patent challenge has been the main focus of investors, Celgene’s pipeline is not being priced into the multiple and represents asymmetric risk on the upside. The firm sees 40% potential upside in six months.